A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults
Clinical trial NCT02335164 · COMPLETED
Trial details
- NCT number
- NCT02335164
- Sponsor
- Vaxine Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-12-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.